Multipl Skleroz Atak Tedavisi
Özet
Referanslar
Hemmer B, Cepok S, Zhou D, Sommer N. Multiple Sclerosis – A Coordinated Immune Attack Across the Blood Brain Barrier. Curr Neurovasc Res. 2004;(1):141-50. doi: 10.2174/1567202043480152
Regina Berkovich. Treatment of Acute Relapses in Multiple Sclerosis. Neurotherapeutics. 2013 Jan;10(1):97-105. doi: 10.1007/s13311-012-0160-7.
Jagannadha Avasarala. Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms. Innov Clin Neurosci. 2017 Apr 1;14(3-4):38-40.
Yamout B, Al-Jumah M, Sahraian MA, Almalik Y, Al Khaburi J, Shalaby N et al. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines. Mult Scler Relat Disord. 2024 Mar:83:105435. doi:10.1016/j.msard.2024.105435.
Talanki Manjunatha R, Habib S, Sangaraju SL, Yepez D, Grandes XA. Multiple Sclerosis: Therapeutic Strategies on the Horizon. Cureus. 2022 May 10;14(5):e24895. doi: 10.7759/cureus.24895. PMID: 35706718; PMCID: PMC9187186.
Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 2018 Feb 21;97(4):742-768. doi: 10.1016/j.neuron.2018.01.021. PMID: 29470968.
Ramo-Tello C, Blanco Y, Brieva L, Casanova B, Martínez-Cáceres E, Ontaneda D, Ramió-Torrentá L, Rovira À. Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses. J Pers Med. 2021 Dec 22;12(1):6. doi: 10.3390/jpm12010006. PMID: 35055321; PMCID: PMC8780774.
Matthews WB. Paroxysmal symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1975 Jun;38(6):617-23. doi: 10.1136/jnnp.38.6.617. PMID: 1151430; PMCID: PMC492038.
Nos C, Sastre-Garriga J, Borràs C, Río J, Tintoré M, Montalban X. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis. Mult Scler. 2004 Aug;10(4):413-6. doi: 10.1191/1352458504ms1068oa. PMID: 15327039.
Hirst CL, Ingram G, Pickersgill TP, Robertson NP. Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome. Mult Scler. 2012 Aug;18(8):1152-8. doi: 10.1177/1352458511433919. Epub 2012 Jan 4. PMID: 22217582.
Repovic P. Management of Multiple Sclerosis Relapses. Continuum (Minneap Minn). 2019 Jun;25(3):655-669. doi: 10.1212/CON.0000000000000739. PMID: 31162310.
Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA; Canadian MS Working Group. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6. PMID: 32654681.
Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA; Canadian MS Working Group. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6. PMID: 32654681.
Blechinger S, Ehler J, Bsteh G, Winkelmann A, Leutmezer F, Meister S et al. Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study. Ther Adv Neurol Disord. 2021 Jan 27:14:1756286420975642. doi: 10.1177/1756286420975642.
Jancic J, Nikolic B, Ivancevic N, Djuric V, Zaletel I, Stevanovic D, Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options. Neurology and Therapy, 2016:(5),131-143.
Jancic J, Nikolic B, Inancevic N, Hencic B, Samardzic J, Zagon IS, McLaughlin PJ. Multiple Sclerosis Therapies in Pediatric Patients: Challenges and Opportunities. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis [Internet]. Brisbane (AU): Codon Publications; 2017 Nov 27. Chapter 3. doi: 10.15586/codon.multiplesclerosis.2017.ch3
Marrodan M, Crema S, Rubstein A, Alessandro L, Fernandez J, Correale J, Ysrraleit MC. Therapeutic plasma exchange in MS refractory relapses: Long-term outcome. Mult Scler Relat Disord. 2021 Oct:55:103168. doi: 10.1016/j.msard.2021.103168.
Bunganic R, Blahutova S, Revendova K, Zapletalova O, Hradilek P, Hrdlickova R et al. Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center. Sci Rep. 2022 Nov 1;12(1):18374. doi: 10.1038/s41598-022-23356-w
Menascu S, Siegel-Kirshenbaum M, Dreyer-Alster S, Warszawer Y, Magalashvili D, Dolev M et al. Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis. Mult Scler J Exp Transl Clin. 2023 Jan 17;9(1):20552173221151127. doi: 10.1177/20552173221151127.
francesco Patti, Salvatore Lo Fermo. Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis. Autoimmune Dis. 2011 Mar 15:2011:961702. doi: 10.4061/2011/961702.
Mahboobeh Fereidan-Esfahani, W Oliver Tobin. Cyclophosphamide in treatment of tumefactive multiple sclerosis. Mult Scler Relat Disord. 2021 Jan:47:102627. doi: 10.1016/j.msard.2020.102627.
